Rovi stock trades at EUR 58.65 with a P/ E ratio of 16.2

Published on 10/12/2026 at 13:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The average target is EUR 74.36 across four analysts. Rovi stock traded at EUR 58.65 on October 12, 2026, below EUR 86.70 high.

Key points in brief

Rovi stock traded at EUR 58.65 at Lang & Schwarz on October 12, 2026.
The company had a EUR 3.0 billion market capitalization and a P/E ratio of 16.20.
The average analyst target was EUR 74.36 across four ratings, while nine-month results were scheduled for November 5, 2026.

Rovi, ES0157261019, Illustration mit AI erstellt.

Rovi (ISIN ES0157261019) traded at EUR 58.65 at Lang & Schwarz on October 12, 2026 at 1:02 p.m. CEST, while its P/E ratio stood at 16.20. The price was EUR 28.05 below the 52-week high of EUR 86.70, a gap of 32.35 percent based on the same euro quotation.

Valuation stays central

Rovi's market capitalization was EUR 3.0 billion as of October 12, 2026. That valuation places the pharmaceutical company in a mid-cap segment of the Madrid market, while the P/E ratio gives investors a clear measure for comparing the share with other listed drugmakers.

According to Investing.com on October 12, 2026, the average 12-month price target was EUR 74.36, based on four analyst recommendations. The target was EUR 15.71 above the Lang & Schwarz price, which equals 26.76 percent upside relative to the current euro quotation.

Comparison with peers

Rovi: P/E 16.20, market capitalization EUR 3.0 billion.

Grifols (Madrid, EUR): daily change plus 1.52 percent, P/E 14.93, market capitalization EUR 6.8 billion.

Pharma Mar (Madrid, EUR): daily change minus 0.94 percent, P/E 21.08, market capitalization EUR 1.2 billion.

Results date sets the calendar

Rovi's next scheduled reporting date is November 5, 2026, when the company is due to publish its results for the first nine months of 2026. Simply Wall St reported the date for Laboratorios Farmaceuticos Rovi on October 11, 2026.

The combination of a 16.20 P/E ratio, a EUR 3.0 billion market value and a EUR 74.36 average target gives the share a valuation-led profile. The EUR 86.70 high remains the key reference point for the 52-week range, while the November reporting date offers the next scheduled company-specific event.

Rovi stock remains below its high

At Lang & Schwarz, Rovi stock was trading at EUR 58.65 on October 12, 2026 at 1:02 p.m. CEST. The 52-week range was EUR 53.10 to EUR 86.70, and the stock was EUR 4.55 above its low.

The further course of trading is shown by the continuously updated real-time quote of Rovi stock.